These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22812001)

  • 1. [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].
    Peng YM; Wang N; Wang YF; Han L; Zhang Y; Jiang JH; Zhou YB; Wang QD
    Yao Xue Xue Bao; 2012 May; 47(5):594-9. PubMed ID: 22812001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX
    Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent Resistance to adriamycin in human lukemia cell line K562/A02].
    Wang JQ; Chen BA; Cheng J; Xu WL; Sun XC
    Ai Zheng; 2008 May; 27(5):491-5. PubMed ID: 18479598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Ji BS; He L; Liu GQ
    Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of tetrandrine, toremifene and their combination on the reversion of multidrug resistance of K562/A02 cell line].
    Zhao QX; Chen BA; Cheng J; Ding JH; Gao F; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):61-4. PubMed ID: 18315901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Xu HB; Li L; Liu GQ
    Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
    Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reversal effect and its mechanism of ampelopsin on multidrug resistance in K562/ADR cells].
    Ye J; Zheng Y; Liu D
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):761-5. PubMed ID: 19624024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].
    Han YQ; Yuan JY; Shi YJ; Zhu Y; Wu SL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):604-8. PubMed ID: 14706144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
    Li F; Fan J; Wu Z; Liu RY; Guo L; Dong Z; Wang Z
    Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
    Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo.
    Li H; Yan Z; Ning W; Xiao-Juan G; Cai-Hong Z; Jin-Hua J; Fang M; Qing-Duan W
    J Biomed Biotechnol; 2011; 2011():281651. PubMed ID: 21765632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversal of multidrug resistance by lomerizine in K562/ADM cells].
    Zhu HJ; Wu YL; Liu GQ
    Yao Xue Xue Bao; 2004 May; 39(5):333-7. PubMed ID: 15338873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversal of multidrug resistance in drug-resistant human breast cancer cell line MCF-7/ADR by calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine].
    Cheng YH; Qi J; Xiong DS; Liu JW; Qi SL; Pan B; Yang CZ; Zhu HF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):164-8. PubMed ID: 16733896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.